![](/img/cover-not-exists.png)
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation
Mian, A A, Rafiei, A, Haberbosch, I, Zeifman, A, Titov, I, Stroylov, V, Metodieva, A, Stroganov, O, Novikov, F, Brill, B, Chilov, G, Hoelzer, D, Ottmann, O G, Ruthardt, MVolume:
29
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2014.326
Date:
May, 2015
File:
PDF, 5.56 MB
english, 2015